Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 13.66M
March 31, 2026 25.26M
December 31, 2025 8.439M
September 30, 2025 -52.85M
June 30, 2025 61.88M
March 31, 2025 32.76M
December 31, 2024 32.38M
September 30, 2024 -12.43M
June 30, 2024 6.975M
March 31, 2024 -109.20M
December 31, 2023 -21.63M
September 30, 2023 -126.13M
June 30, 2023 -0.811M
March 31, 2023 -0.136M
December 31, 2022 -1.483M
September 30, 2022 -3.677M
June 30, 2022 -5.06M
March 31, 2022 -0.874M
December 31, 2021 -2.194M
September 30, 2021 -2.015M
June 30, 2021 -4.564M
Date Value
March 31, 2021 2.435M
December 31, 2020 1.523M
September 30, 2020 -0.788M
June 30, 2020 -0.935M
March 31, 2020 -0.426M
December 31, 2019 -0.544M
September 30, 2019 -15.00M
June 30, 2019 -3.913M
March 31, 2019 -5.917M
December 31, 2018 -0.107M
September 30, 2018 -1.656M
June 30, 2018 -0.242M
March 31, 2018 -3.449M
December 31, 2017 -0.339M
September 30, 2017 -0.13M
June 30, 2017 -0.496M
March 31, 2017 -0.167M
December 31, 2016 -0.436M
September 30, 2016 -0.131M
June 30, 2016 -0.133M
March 31, 2016 -0.126M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -0.513M
Codexis, Inc. 0.175M
Frontage Holdings Corp. --
Repligen Corp. -2.089M
Bio-Techne Corp. -7.057M